HIM
THC icon

Hillsdale Investment Management’s Tenet Healthcare THC Stock Holding History

Hillsdale Investment Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
31,490
+3,100
+11% +$570K 0.13% 206
2026
Q1 		$5.36M Buy
28,390
+900
+3% +$190K 0.15% 176
2025
Q4 		$5.46M Buy
27,490
+4,690
+21% +$948K 0.15% 184
2025
Q3 		$4.63M Buy
22,800
+5,400
+31% +$958K 0.14% 209
2025
Q2 		$3.06M Buy
+17,400
New +$2.62M 0.11% 238
2025
Q1 		– Sell
-5,600
Closed -$707K – 705
2024
Q4 		$707K Buy
5,600
+1,000
+22% +$149K 0.04% 315
2024
Q3 		$765K Buy
+4,600
New +$696K 0.06% 276
2023
Q4 		– Sell
-7,150
Closed -$471K – 645
2023
Q3 		$471K Buy
+7,150
New +$535K 0.04% 292
2022
Q4 		– Sell
-80,170
Closed -$4.14M – 625
2022
Q3 		$4.14M Sell
80,170
-12,700
-14% -$754K 0.37% 101
2022
Q2 		$4.88M Hold
92,870
– – 0.39% 83
2022
Q1 		$7.98M Sell
92,870
-3,730
-4% -$306K 0.52% 35
2021
Q4 		$7.89M Sell
96,600
-2,500
-3% -$183K 0.53% 38
2021
Q3 		$6.58M Sell
99,100
-2,000
-2% -$142K 0.51% 42
2021
Q2 		$6.77M Sell
101,100
-4,000
-4% -$248K 0.54% 33
2021
Q1 		$5.46M Buy
105,100
+24,200
+30% +$1.22M 0.46% 58
2020
Q4 		$3.23M Buy
+80,900
New +$2.61M 0.31% 117
2020
Q2 		– Sell
-26,200
Closed -$377K – 684
2020
Q1 		$377K Buy
+26,200
New +$752K 0.05% 345
2018
Q4 		– Sell
-45,200
Closed -$1.29M – 646
2018
Q3 		$1.29M Buy
45,200
+3,000
+7% +$99K 0.17% 141
2018
Q2 		$1.42M Buy
+42,200
New +$1.31M 0.17% 123
2013
Q3 		– Sell
-7,875
Closed -$363K – 565
2013
Q2 		$363K Buy
+7,875
New +$353K 0.12% 120

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Hillsdale Investment Management's THC Position: Q2 2026 in Review

Hillsdale Investment Management increased its Tenet Healthcare (THC) stake by 11% in Q2 2026, buying an estimated $570K and bringing the position to 31,490 shares worth $5.89M. The position accounts for 0.13% of the portfolio, ranked #206.

Hillsdale Investment Management first reported a position in THC in Q2 2013 and has held it in 20 quarters since. The position peaked at $7.98M in Q1 2022. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Hillsdale Investment Management held 31,490 shares of Tenet Healthcare worth $5.89M as of Q2 2026.
  • Hillsdale Investment Management bought 3,100 Tenet Healthcare shares in Q2 2026, an estimated $570K.
  • Tenet Healthcare made up 0.13% of Hillsdale Investment Management's portfolio in Q2 2026, its #206 holding.
  • Hillsdale Investment Management first reported a position in Tenet Healthcare in Q2 2013 and has held it in 20 quarters since.
  • Hillsdale Investment Management's Tenet Healthcare position peaked at $7.98M in Q1 2022.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.